Summary
Epidemiology and modelling of indirectly transmitted macroparasites
Motivation: Macroparasites are important causes of morbidity worldwide. Apart from the direct effects of infection, they may also have immunosuppressive effects that render hosts vulnerable to more lethal pathogens. Indirectly-transmitted helminth infections are particularly complex. The lifecycle of these parasites involves more than one host for their transmission; the lifespan of the worms may be long in comparison to that of the hosts, and morbidity is associated with the intensity of infection. All this poses challenging problems for the development of mathematical frameworks for their population dynamics and the effect on these dynamics of control interventions.
Human onchocerciasis, better known as ‘River blindness’ has been endemic in 34 tropical countries. Although the Onchocerciasis Control Programme (OCP) in West Africa (1975-2002) has greatly improved the situation in its 11 participating countries, infection by Onchocerca volvulus (the causal agent of River Blindness) still poses an important public health problem in many areas of Africa, Yemen, and Latin America. In Latin America, the Amazonian focus (between Venezuela and Brazil) has levels of infection prevalence, intensity, and transmission similar to those present in West Africa before the inception of OCP. Onchocerciasis is one of the Neglected Tropical Diseases (NTDs). Collectively, the NTDs impose disease burdens similar to those of HIV and Malaria. The NTDs include the filariases, the schistosomiases, the soil-transmitted helminthiases, the trypanosomiases and leishmaniases, and bacterial infections such as trachoma, among others.
Publications
Journals
Mutono N, Basáñez M-G, James A, et al., 2024, Elimination of transmission of onchocerciasis (river blindness) with long-term ivermectin mass drug administration with or without vector control in sub-Saharan Africa: a systematic review and meta-analysis., Lancet Glob Health
Turner H, Kura K, Roth B, et al., 2024, An updated economic assessment of moxidectin treatment strategies for onchocerciasis elimination, Clinical Infectious Diseases, ISSN:1058-4838
Colebunders R, Siewe Fodjo JN, Kamoen O, et al., 2024, Treatment and prevention of epilepsy in onchocerciasis-endemic areas is urgently needed, Infectious Diseases of Poverty, Vol:13, ISSN:2049-9957
Freitas LT, Khan MA, Uddin A, et al., 2024, The lymphatic filariasis treatment study landscape: a systematic review of study characteristics and the case for an individual participant data platform, Plos Neglected Tropical Diseases, Vol:18, ISSN:1935-2727
Otabil KB, Basáñez M-G, Ankrah B, et al., 2023, Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study., Bmc Infect Dis, Vol:23